US 8623869
Compounds useful as inhibitors of ATR kinase
granted A61KA61K31/4985A61K45/06
Quick answer
US patent 8623869 (Compounds useful as inhibitors of ATR kinase) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 42
- CPC classes
- A61K, A61K31/4985, A61K45/06, A61P, A61P35/00